modified standard brite tip sheath-introduttore
cordis corporation - introduttori valvolati per apparato cardiocircolatorio
modified adams clasp
tp orthodontics inc. - fili per ortodonzia
modified meyerding (right)
omni-tract surgical, a division of minnesota scientific, inc - divaricatori e retrattori per chirurgia generale - altri
modified meyerding (left)
omni-tract surgical, a division of minnesota scientific, inc - divaricatori e retrattori per chirurgia generale - altri
modified ham's f-10 basal medium
irvine scientific - dispositivi per procreazione assistita - altri
comirnaty
biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaccini - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. l'uso di questo vaccino dovrebbe essere in conformità con le raccomandazioni ufficiali.
natrixam 1.5mg/5mg compresse a rilascio modificato
servier (suisse) sa - indapamidum, amlodipinum - compresse a rilascio modificato - indapamidum 1.5 mg, hypromellosum, lactosum monohydricum 104.5 mg, magnesii stearas, povidonum k 30, silica colloidalis anhydrica, amlodipinum 5 mg ut amlodipini besilas 6.935 mg, calcii hydrogenophosphas dihydricus, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.69 mg, magnesii stearas, amylum pregelificatum, silica colloidalis anhydrica, pellicule: glycerolum, hypromellosum, macrogolum 6000, magnesii stearas, e 171, pro compresso obducto. - ipertensione - synthetika
natrixam 1.5mg/10mg compresse a rilascio modificato
servier (suisse) sa - indapamidum, amlodipinum - compresse a rilascio modificato - indapamidum 1.5 mg, hypromellosum, lactosum monohydricum 104.5 mg, magnesii stearas, povidonum k 30, silica colloidalis anhydrica, amlodipinum 10 mg ut amlodipini besilas 13.87 mg, calcii hydrogenophosphas dihydricus, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.69 mg, magnesii stearas, amylum pregelificatum, silica colloidalis anhydrica, pellicule: glycerolum, hypromellosum, macrogolum 6000, magnesii stearas, e 171, e 172, pro compresso obducto. - ipertensione - synthetika
gliclazid mr servier 30mg compresse a rilascio modificato
servier (suisse) sa - gliclazidum - compresse a rilascio modificato - gliclazidum 30 mg, excipiens pro compresso. - il diabete orale - synthetika